InsiderTrades.com logo
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

GFL Insider Trading

Insider Ownership Percentage: 63.14%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Global Masters Fund Insider Trading History Chart

This chart shows the insider buying and selling history at Global Masters Fund by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Global Masters Fund Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 08/16/2019 01:00 AM ET

This chart shows the closing price history over time for GFL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

Global Masters Fund Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/21/2022Emmanuel (Manny) PohlInsiderTransfer635,947A$2.38A$1,513,553.86
2/18/2022Emmanuel (Manny) PohlInsiderTransfer120,967A$3.31A$400,400.77
11/24/2021Angela ObreeInsiderIssued3,226A$2.50A$8,065.00
See Full Table
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for Global Masters Fund (ASX:GFL)

0.59% of Global Masters Fund stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Global Masters Fund logo
Global Masters Fund Limited is a close ended equity mutual fund launched and managed by Growth Equities Corporation Ltd. The fund invests in the stocks of Berkshire Hathaway Inc. Global Masters Fund Limited is domiciled in Australia.
Read More on Global Masters Fund

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.41

Who are the company insiders with the largest holdings of Global Masters Fund?

Global Masters Fund's top insider shareholders include:
  1. Emmanuel (Manny) Pohl (Insider)
Learn More about top insider investors at Global Masters Fund.
Jim Cramer’s “The Biggest Drug Ever”
From Behind the Markets   |   Ad
This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.
Unlock the details of this groundbreaking opportunity here...